Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W0JP
|
|||
| Former ID |
DIB015551
|
|||
| Drug Name |
OMS405
|
|||
| Indication | Nicotine dependence [ICD-11: 6C4A.2; ICD-10: F17.2; ICD-9: 305.1] | Phase 2 | [1] | |
| Opioid dependence [ICD-11: 6C43.2Z] | Phase 2 | [2] | ||
| Company |
Omeros
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035962) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of Avarx. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.